The role of SP-D in human colonic inflammatory bowel disease and in murine DSS induced colitis by Nexøe, Anders Bathum et al.
Syddansk Universitet
The role of SP-D in human colonic inflammatory bowel disease and in murine DSS
induced colitis
Nexøe, Anders Bathum; Pilecki, Bartosz; Leicht von Huth, Sebastian ; Husby, Steffen;
Pedersen, Andreas A; Detlefsen, Sönke; Marcussen, Niels; Holmskov, Uffe; Sørensen, Grith
Lykke
Publication date:
2017
Document version
Også kaldet Forlagets PDF
Citation for pulished version (APA):
Nexøe, A. B., Pilecki, B., Leicht von Huth, S., Husby, S., Pedersen, A. A., Detlefsen, S., ... Sørensen, G. L.
(2017). The role of SP-D in human colonic inflammatory bowel disease and in murine DSS induced colitis.
Poster session præsenteret ved 44th Annual Meeting of the Scandinavian Society of Immunology, Stockholm,
Sverige.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 08. Jan. 2018
The Role of SP-D in Human Colonic Inflammatory Bowel Disease and in Murine 
Dextran Sodium Sulfate Induced Colitis
Anders B. Nexoe1, Bartosz Pilecki1,  Sebastian von Huth1, Steffen Husby2, Andreas A. Pedersen2, Sönke Detlefsen3, Niels Marcussen3, Jesper 
B. Moeller4, Uffe Holmskov1, Grith L. Sorensen1
1Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark, 2H. C. Andersen Children’s Hospital, Odense University Hospital, 
Odense, Denmark, 3Department of Pathology, Odense University Hospital, Denmark, 4Weill Cornell Medicine, New York, USA.
BACKGROUND
SP-D is a collectin widely distributed on mucosal surfaces of the body
including the gastrointestinal tract (1). It is part of the innate immune system
and mediates control of pro-inflammatory mechanisms.
Genetic variations of SP-D have recently been associated to inflammatory
bowel disease (IBD) in a Japanese population and showed association to
ulcerative colitis (UC) (2). In contrast, an American case-control analysis
revealed a significant association between a specific SP-D genetic variant
and susceptibility to Crohn’s disease (CD), but not to UC (3).
Together these two studies suggest that SP-D is involved in IBD and warrant
in vivo studies of the related pathophysiological mechanisms.
AIM
We aimed to investigate the expression of SP-D in IBD patients and
compared it to the intestinal inflammatory activity, and we compared the
inflammatory response between Sftpd+/+ (WT) and Sftpd-/- (KO) mice in a
dextran sodium sulfate (DSS) model of colitis.
We hypothesized that SP-D dampens intestinal inflammation by reducing
innate inflammatory signaling and facilitate clearance of apoptotic cells.
METHODS
Surgical specimens from IBD patients (n=27) including Crohn’s disease
(CD) (n=9) and ulcerative colitis (UC) (n=18) were immunohistochemically
stained for SP-D. The tissue specimens was scored for SP-D expression
and inflammatory activity.
Colitis was induced in WT and KO littermates by supplementing the ad
libitum water with DSS.
Colon tissue were stained with hematoxylin & eosin to estimate the
histological damage, and immunohistochemical staining’s were used to
analyze levels of apoptosis, necrosis and inflammatory infiltration.
Colon tissue samples were analyzed for inflammatory markers (TNF-α, IL-6,
INF-γ and CCL-2) by ELISA analysis.
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CONCLUSION
- Limited anti-inflammatory effects of SP-D  in DSS-induced 
inflammation in mice. 
- Positive correlation between inflammatory activity and immunoscore
for SP-D observed in surgical specimens from IBD patients.
- SP-D is upregulated in clinical disease.
Day 0: 
Start of treatment 
with DSS
Day 7: 
Mice receiving 1.5% 
DSS are terminated
1% DSS is replaced 
with water
Day 10: 
Mice are terminated 
after receiving water 
for 3 days
RESULTS
- We found a significant correlation between the expression of intestinal
SP-D and inflammatory activity in IBD patients (Fig. 1).
- Mice treated with DSS did experience a notable weight loss and
increased disease activity index (DAI) score (Fig. 2), but there were no
difference between WT and KO.
- ELISA analysis showed a significant difference in the levels of TNF-α
between WT and KO in the restitution phase and qRT-PCR did show a
tendential upregulation of Sftpd in WT mice treated with DSS (Fig. 3, A-
B). There were no difference in histologic damage or colon length
between WT and KO (Fig. 3, C-D).
Fig. 3: A) ELISA analysis showed a significant difference between colonic
levels of TNF-α in WT compared to KO in the restitution phase. B) Quantative
real-time PCR of murine expression of SP-D in the colon. C) Histological
damage score. D) Length of colon. All data are presented with SEM.
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Fig. 1: A) Correlation of immunoscore and inflammatory activity in surgical
specimens from IBD patients. B) Immunostaining for SP-D in a patient with
UC. C) Immunostaining for SP-D in a patient with CD
Fig. 2: A) Weight loss. B) DAI score. All data are presented with SEM.
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